Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service？ Thank you for choosing ACROBiosystems. Would you rate our product and service？
Here come GMP Grade Cytokines！Free Sample is available！ Here come GMP Grade Cytokines！Free Sample is available！
| 製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
|---|---|---|---|---|---|
| CXR-H5222 | Human | Human CXADR / CAR Protein, His Tag |  |
|
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Upacicalcet | SK-1403; AJT-240 | Approved | Ajinomoto Co Inc | ウパシタ, Upasita | Japan | Hyperparathyroidism, Secondary | Sanwa Kagaku Kenkyusho Co Ltd | 2021-06-23 | Hyperparathyroidism, Secondary | Details |
| Evocalcet | KHK-7580; MT-4580 | Approved | Mitsubishi Tanabe Pharma Corp | Orkedia | Japan | Hyperparathyroidism, Secondary | Kyowa Hakko Kirin Co Ltd | 2018-03-23 | Hyperparathyroidism, Secondary; Parathyroid Neoplasms; Hyperparathyroidism, Primary; Hyperparathyroidism | Details |
| Etelcalcetide Hydrochloride | KAI-4169; AMG-416; KAI-4169-HCl; ONO-5163 | Approved | Amgen Inc | Parsabiv | United States | Hyperparathyroidism, Secondary | Kai Pharmaceuticals Inc | 2016-11-11 | Hyperparathyroidism, Secondary; Edema, Cardiac; Renal Insufficiency, Chronic; Kidney Failure, Chronic | Details |
| Cinacalcet Hydrochloride | KRN-1493; SSS-12; AMG-073.HCl; NPS-1493; AMG-073 | Approved | Amgen Inc | Parareg, Sensipar, Mimpara, Regpara, 盖平, Sensipar/Mimpara | Mainland China | Hyperparathyroidism, Secondary; Hyperparathyroidism; Hypercalcemia | Kyowa Hakko Kirin Co Ltd | 2004-03-08 | Hyperparathyroidism, Secondary; Rejection of renal transplantation; Hypophosphatemia; Nephrosis; Parathyroid Neoplasms; Edema, Cardiac; Hypercalcemia; Kidney Diseases; Hyperparathyroidism, Primary; Prostatic Neoplasms; Osteomalacia; Renal Insufficiency, Chronic; Hyperparathyroidism; Kidney Failure, Chronic; Chronic Kidney Disease-Mineral and Bone Disorder | Details |
| Strontium Ranelate | FK-481; S-12911; S-12911-2 | Approved | Laboratoires Servier | 欧思美, Osseor, Protos, Protelos | Mainland China | Osteoporosis, Postmenopausal | Les Laboratoires Servier | 2004-09-20 | Osteoporosis, Postmenopausal | Details |
| Parathyroid hormone (Shire) | NPSP-795; rhPTH (1-84); rhPTH-1-84; PTH (1-84); SB-423562; PTH 1-84; NPSP-558; SHP-635; SHP-634; ALX-111; 423562; EBP-05; EB-612 | Approved | Shire | Natpara, Preotact, Natpar | EU | Hypoparathyroidism | Takeda Pharmaceuticals International AG Ireland Branch | 2006-04-24 | Osteoporosis; Bone Diseases, Endocrine; Osteoporosis, Postmenopausal; Hypocalcemia; Psoriasis; Hypoparathyroidism; Hyperparathyroidism | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| DS-9194b | DS-9194b | Phase 1 Clinical | Daiichi Sankyo Co Ltd | Osteoporosis | Details |
| ASP-7991 | ASP-7991 | Astellas Pharma Inc | Details | ||
| LNP-1892 | LNP-1892 | Phase 2 Clinical | Rubin Ltd | Hyperparathyroidism | Details |
| Encaleret sulfate | MK-5442; JTT-305; CLTX-305 | Phase 2 Clinical | Japan Tobacco (Hong Kong) Ltd | Osteoporosis; Hypocalcemia; Osteoporosis, Postmenopausal; Hypoparathyroidism | Details |
| RT-102(Rani) | RT-102 | Phase 1 Clinical | Rani Therapeutics Holdings Inc | Osteoporosis | Details |
This web search service is supported by Google Inc.
アクロバイオシステムズの公式アカウント
A-Z
